Secukinumab Dosage Optimisation in Partial Responders With Moderate to Severe Plaque-type Psoriasis
Clinical trial NCT02474069 · COMPLETED
Trial details
- NCT number
- NCT02474069
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-08
- Primary completion
- 2016-09-15
- Enrollment
- 772
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.